The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluation of safety and tolerability of durvalumab (D) with or without tremelimumab (T) in patients (pts) with biliary tract cancer (BTC).
 
Tatsuya Ioka
Consulting or Advisory Role - AstraZeneca; Baxalta; Taiho Pharmaceutical; Yakult Honsha
Speakers' Bureau - Chugai Pharma; Daiichi Sankyo; Eisai; Mochida Pharmaceutical Co. Ltd.; Nihonkayaku; Taiho Pharmaceutical; Yakult Honsha
Research Funding - AstraZeneca (Inst); Bayer (Inst); GlaxoSmithKline (Inst); Merck Serono (Inst); Nihon Zouki (Inst); Taiho Pharmaceutical; Zeria Pharmaceutical
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline; Merck Serono
 
Makoto Ueno
Honoraria - AstraZeneca; Lilly; Novartis; Ono Pharmaceutical; Shire; Taiho Pharmaceutical; Teijin Pharma; Yakult Honsha
Consulting or Advisory Role - Shire
Research Funding - ASLAN Pharmaceuticals (Inst); AstraZeneca (Inst); Daiichi Sankyo (Inst); Dainippon Sumitomo Pharma (Inst); Eisai (Inst); Incyte (Inst); Merck Serono (Inst); MSD (Inst); NanoCarrier (Inst); Ono Pharmaceutical (Inst); Shire (Inst); Taiho Pharmaceutical (Inst)
 
Do-Youn Oh
Consulting or Advisory Role - AstraZeneca; Merck Serono
Research Funding - AstraZeneca
 
Yutaka Fujiwara
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; MSD; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - AbbVie; AstraZeneca; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Eisai; Incyte; Lilly; Merck Serono; MSD; Novartis
 
Jen-Shi Chen
Consulting or Advisory Role - Ono Pharmaceutical
Research Funding - Daiichi Sankyo; Lilly; MedImmune; MSD Oncology; Ono Pharmaceutical; orient EuroPharma; TTY Biopharm
 
Yuichiro Doki
No Relationships to Disclose
 
Nobumasa Mizuno
Honoraria - Novartis; Ono Pharmaceutical; Taiho Pharmaceutical; Teijin Pharma; Yakult Honsha
Consulting or Advisory Role - Teijin Pharma
Research Funding - ASLAN Pharmaceuticals (Inst); AstraZeneca (Inst); Dainippon Sumitomo Pharma (Inst); Eisai (Inst); Incyte (Inst); Merck Serono (Inst); MSD (Inst); NanoCarrier (Inst); Novartis (Inst); Pharma Valley Center (Inst); Taiho Pharmaceutical (Inst); Yakult Honsha (Inst); Zeria Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Eisai; Novartis; Taiho Pharmaceutical
 
Keunchil Park
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; GlaxoSmithKline; Hanmi; Kyowa Hakko Kirin; Lilly; MSD; Novartis; Ono Pharmaceutical; Roche
Speakers' Bureau - AZD; Boehringer Ingelheim
Research Funding - AstraZeneca
 
Akinori Asagi
Honoraria - Novartis; Ono Pharmaceutical; Taiho Pharmaceutical; Teijin Pharma; Yakult Honsha
Research Funding - ASLAN Pharmaceuticals (Inst); AstraZeneca (Inst); Dainippon Sumitomo Pharma (Inst); Eisai (Inst); Incyte (Inst); Merck Serono (Inst); MSD (Inst); NanoCarrier (Inst); Novartis (Inst); Pharma Valley Center (Inst); Taiho Pharmaceutical (Inst); Yakult Honsha (Inst); Zeria Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Eisai; Novartis; Taiho Pharmaceutical
 
Manabu Hayama
Employment - AstraZeneca
 
Masahiro Nii
Employment - AstraZeneca
 
Keiko Komuro
Employment - AstraZeneca
 
Mariko Sugimoto
Employment - AstraZeneca
 
Gordana Vlahovic
Honoraria - Genentech/Roche; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech/Roche; Pfizer
Speakers' Bureau - Genentech/Roche; Pfizer
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Genentech/Roche; Pfizer
 
Masafumi Ikeda
Honoraria - Abbott Japan; Bayer Yakuhin; Bristol-Myers Squibb Japan; Dainippon Sumitomo Pharma; Eisai; Lilly Japan; Nobelpharma; Novartis; Otsuka; Taiho Pharmaceutical; Teijin Pharma; Yakult Honsha
Consulting or Advisory Role - Bayer Yakuhin; Daiichi Sankyo; Eisai; Kyowa Hakko Kirin; Lilly Japan; MSD; NanoCarrier; Novartis; Shire; Teijin Pharma
Research Funding - ASLAN Pharmaceuticals; AstraZeneca; Baxalta/Shire; Bayer Yakuhin; Bristol-Myers Squibb; Chugai Pharma; Eisai; Kowa; Kyowa Hakko Kirin; Lilly Japan; Merck Serono; MSD; NanoCarrier; Novartis; Ono Pharmaceutical; Taiho Pharmaceutical; Takara Bio; Yakult Pharmaceutical